All Access Pass - 1 FREE Month!
Institutional email required, no credit card necessary.

Parkinson's Disease for USMLE Step 2 / COMLEX-USA Level 2

FREE ONE-MONTH ACCESS
Institutional (.edu or .org) Email Required
Register Now!
No institutional email? Start your 1-week free trial, now!
Clinical Presentation
  • Motor Symptoms:
    • Bradykinesia: Significant slowness of movement, difficulty initiating movements.
    • Rigidity: Stiffness in muscles throughout the body.
    • Resting Tremor: Noticeable shaking, typically a "pill-rolling" tremor of the hands at rest.
    • Postural Instability: Poor balance and coordination, risk of falls.
  • Non-Motor Symptoms:
    • Cognitive Decline: Ranging from mild impairment to dementia in advanced stages.
    • Mood Disorders: Depression and anxiety are common.
    • Autonomic Dysfunction: Issues like constipation, urinary urgency, orthostatic hypotension.
    • Sleep Disturbances: Especially REM sleep behavior disorder.
Diagnostic Approach
  • Clinical Diagnosis: Based on motor symptoms and response to dopaminergic therapy.
  • Supportive Tests:
    • DaTscan: Helps differentiate PD from other types of parkinsonism by assessing dopamine transporter levels in the brain.
    • MRI: Used to rule out other causes of symptoms but not diagnostic for PD.
Management
  • Pharmacological Treatment:
    • Levodopa/Carbidopa: Most effective for symptomatic control, monitored for dose adjustments based on response and side effects.
    • Dopamine Agonists: Pramipexole, ropinirole—used in younger patients or early disease.
    • MAO-B Inhibitors: Selegiline, rasagiline—used either alone in early disease or as adjunct therapy.
    • COMT Inhibitors: Entacapone, tolcapone—enhance effects of Levodopa.
  • Non-Pharmacological:
    • Physical Therapy: Focus on mobility, strength, and balance.
    • Occupational Therapy: Help with daily activities and adaptive techniques.
    • Speech Therapy: For speech and swallowing issues.
Complications and Monitoring
    • Motor Fluctuations and Dyskinesias: Due to long-term Levodopa use.
    • Psychiatric Complications: Particularly hallucinations and psychosis, especially in the elderly or those on higher doses of medication.
    • Neurological Consultation: For complex cases or when diagnosis is uncertain.
High-Yield Items for Step 2
1. Diagnosis of PD: Emphasis on clinical presentation and response to Levodopa. 2. Management Strategies: Detailed knowledge of pharmacological agents used in PD, including their side effects and indications. 3. Differential Diagnosis:
    • Essential Tremor: Distinguished by action tremor and lack of other parkinsonian features.
    • Drug-Induced Parkinsonism: Caused by dopamine receptor blockers.
    • Atypical Parkinsonisms: Like PSP or MSA, which have additional clinical features and poor response to Levodopa.
4. Role of Multidisciplinary Team: Importance of physical, occupational, and speech therapy in managing the disease.